-transparent.png){kind=logo}
It has become promising to establish a method for mass screening of colorectal cancer through the development of immunological fecal occult blood test. It has been shown that such tests have higher specificity and sensitivity compared to conventional chemical tests not only in cancer subjects and normal controls but in population screening trials. Further study is required to decide the optimal system within the framework of the screening such as the number of specimens, target age, and screening interval, etc. The efficacy of fecal occult blood screening remains to be shown in spite of the several randomized controlled trials completed or on-going. However, a case control study has strongly suggested that such screening would reduce the mortality from colorectal cancer.
H Saito, and
Y Soma, and
H Kawaguchi
April 2021,
Revista medica de Chile,
H Saito, and
Y Soma, and
H Kawaguchi
January 2002,
Annals of oncology : official journal of the European Society for Medical Oncology,
H Saito, and
Y Soma, and
H Kawaguchi
March 1997,
The Journal of family practice,
H Saito, and
Y Soma, and
H Kawaguchi
January 2002,
Gastrointestinal endoscopy clinics of North America,
H Saito, and
Y Soma, and
H Kawaguchi
December 1986,
Scandinavian journal of gastroenterology,
H Saito, and
Y Soma, and
H Kawaguchi
February 2019,
Journal of digestive diseases,
H Saito, and
Y Soma, and
H Kawaguchi
June 1986,
Cancer,
H Saito, and
Y Soma, and
H Kawaguchi
January 1999,
Acta gastroenterologica Latinoamericana,
H Saito, and
Y Soma, and
H Kawaguchi
November 2001,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
H Saito, and
Y Soma, and
H Kawaguchi
January 1995,
Archives of internal medicine,
